Company attributes
Venture Capital Firm attributes
Other attributes
Bio Capital Impact Fund is a global fund in Australia that focuses on investing in health, agricultural biotechnology, and industrial biotechnology companies. Founded 2016 in Melbourne, Victoria, Australia by Helen Fisher, it invests in venture rounds. Its portfolio companies include NovellusDx. Bio Capital Impact Fund has invested in NovellusDx on April 30, 2018. This investment in the venture round of NovellusDx was valued at $6M. Novellusdx is a company that develops tumor specific driver mutations and focuses on testing targeted therapy drugs on emulated tumors and quantifying their therapeutic effect, monitoring the oncogenic activity of the patient's relevant genes and proteins, and monitoring the oncogenic activity before and after drug administration. Haim Gil-ad and Yoram Altschuler founded it on May 1, 2011, with its headquarters in Jerusalem in Israel.
